LPS by itself is capable of accelerating lung cancer growth in vivo, partially through macrophage infiltration and activation of NF-κB and STAT3 signaling [56], providing an additional route for smoking-induced oncogenesis. Here, NFKB1 is linked to lung carcinoma.